Anew Medical Receives European Patent for Klotho as Treatment for Neurodegenerative Diseases

MT Newswires Live06-26

Anew Medical (WENA) said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia, and other neurodegenerative diseases.

The company said the product's key intellectual property asset is covered under its exclusive worldwide license deal with Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Spain.

Anew Medical it has also patent approval in China and Hong Kong, and that it plans to start product development and further expand its intellectual property portfolios into Asian markets this year.

Price: 1.6200, Change: -0.03, Percent Change: -1.82

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2446357839?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-06-26 17:44","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2446357839","market":"us","top_or_hot":-1,"title":"Anew Medical Receives European Patent for Klotho as Treatment for Neurodegenerative Diseases","media":"MT Newswires Live","content":"<html><body><p> Anew Medical (WENA) said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia, and other neurodegenerative diseases.</p><p>The company said the product's key intellectual property asset is covered under its exclusive worldwide license deal with Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Spain.</p><p>Anew Medical it has also patent approval in China and Hong Kong, and that it plans to start product development and further expand its intellectual property portfolios into Asian markets this year.</p><p>Price: 1.6200, Change: -0.03, Percent Change: -1.82</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Anew Medical Receives European Patent for Klotho as Treatment for Neurodegenerative Diseases</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAnew Medical Receives European Patent for Klotho as Treatment for Neurodegenerative Diseases\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-06-26 17:44 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.mtnewswires.com/><strong>MT Newswires Live</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Anew Medical (WENA) said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, ...</p>\n\n<a href=\"https://www.mtnewswires.com/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK6114","symbol_name":"包装食品与肉类","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2446357839","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2446357839","pubTimestamp":1719395040,"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Anew Medical  said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia, and other neurodegenerative diseases.The company said the product's key intellectual property asset is covered under its exclusive worldwide license deal with Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Spain.Anew Medical it has also patent approval in China and Hong Kong, and that it plans to start product development and further expand its intellectual property portfolios into Asian markets this year.Price: 1.6200, Change: -0.03, Percent Change: -1.82","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK6114":"包装食品与肉类","BK6509":"食品和饮料股","OTS.SI":"OTS Holdings"},"translate_title":"Anew Medical获得Klotho治疗神经退行性疾病的欧洲专利","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OTS.SI":1,"WENA":0.9},"content_text":"Anew Medical (WENA) said Wednesday that it received a patent in Europe for the use of its Klotho gene sequence and gene delivery systems for the treatment of diminished cognition, memory loss, dementia, and other neurodegenerative diseases.The company said the product's key intellectual property asset is covered under its exclusive worldwide license deal with Universitat Autonoma de Barcelona and Institucio Catalana de Recerca i Estudis Avancats in Spain.Anew Medical it has also patent approval in China and Hong Kong, and that it plans to start product development and further expand its intellectual property portfolios into Asian markets this year.Price: 1.6200, Change: -0.03, Percent Change: -1.82","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.28.3","shortVersion":"4.28.3","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2446357839"}